Literature DB >> 30620790

Nuclear FGFR2 regulates musculoskeletal integration within the developing limb.

Joanna E Salva1,2, Ryan R Roberts1,2, Taylor S Stucky1,2, Amy E Merrill1,2.   

Abstract

BACKGROUND: Bent bone dysplasia syndrome (BBDS), a congenital skeletal disorder caused by dominant mutations in fibroblast growth factor receptor 2 (FGFR2), is characterized by bowed long bones within the limbs. We previously showed that the FGFR2 mutations in BBDS enhance nuclear and nucleolar localization of the receptor; however, exactly how shifts in subcellular distribution of FGFR2 affect limb development remained unknown.
RESULTS: Targeted expression of the BBDS mutations in the lateral plate mesoderm of the developing chick induced angulated hindlimbs, a hallmark feature of the disease. Whole-mount analysis of the underlying skeleton revealed bent long bones with shortened bone collars and, in severe cases, dysmorphic epiphyses. Epiphyseal changes were also correlated with joint dislocations and contractures. Histological analysis revealed that bent long bones and joint defects were closely associated with irregularities in skeletal muscle patterning and tendon-to-bone attachment. The spectrum of limb phenotypes induced by the BBDS mutations were recapitulated by targeted expression of wild-type FGFR2 appended with nuclear and nucleolar localization signals.
CONCLUSIONS: Our results indicate that the bent long bones in BBDS arise from disruptions in musculoskeletal integration and that increased nuclear and nucleolar localization of FGFR2 plays a mechanistic role in the disease phenotype. 248:233-246, 2019.
© 2018 Wiley Periodicals, Inc. © 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  bent bone dysplasia syndrome; connective tissue; limb development

Mesh:

Substances:

Year:  2019        PMID: 30620790      PMCID: PMC6474847          DOI: 10.1002/dvdy.9

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  4 in total

Review 1.  Nuclear Fibroblast Growth Factor Receptor Signaling in Skeletal Development and Disease.

Authors:  Creighton T Tuzon; Diana Rigueur; Amy E Merrill
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

2.  FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.

Authors:  Christopher I Milton; Joanna Selfe; Ewa Aladowicz; Stella Y K Man; Carolina Bernauer; Edoardo Missiaglia; Zoë S Walters; Susanne A Gatz; Anna Kelsey; Melanie Generali; Gary Box; Melanie Valenti; Alexis de Haven-Brandon; David Galiwango; Angela Hayes; Matthew Clarke; Elisa Izquierdo; David Gonzalez De Castro; Florence I Raynaud; Vladimir Kirkin; Janet M Shipley
Journal:  Mol Oncol       Date:  2021-12-18       Impact factor: 6.603

3.  Genomic adaptations for arboreal locomotion in Asian flying treefrogs.

Authors:  Wei Wu; Yue-Dong Gao; De-Chun Jiang; Juan Lei; Jin-Long Ren; Wen-Bo Liao; Cao Deng; Zeng Wang; David M Hillis; Ya-Ping Zhang; Jia-Tang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-14       Impact factor: 12.779

Review 4.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.